Angel Vento
Gastroenterology · Miami, FLNPI 1417985490
Payments from drug & device makers
What this record shows
That places this record below the midpoint for gastroenterology clinicians in FL, where the typical reported total is $3,025.
No general payments reported
No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.
$2,522,721in research payments, 2019–2025
Across 145 payments — averaging $17,398 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$1.5M
- Regeneron$637K
- Novartis$196K
- Gilead$111K
- Boehringer Ingelheim$28K
- Merck$24K
- plus $2K from 1 others
How this compares
$0 in reported general payments places this provider in the 0th percentile of 1,388 gastroenterology providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl | 87 | $1,928 |
| Esomeprazole Magnesium | 24 | $1,504 |
| Sucralfate | 54 | $1,391 |
| Dicyclomine Hcl | 66 | $1,352 |
| Pantoprazole Sodium | 27 | $480 |
| Famotidine | 24 | $119 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Miami
- Lukasz KwapiszMiami$1.2M
- Joanna LopezMiami$670K
- Jerry MartelMiami$511K
- Andres GelrudMiami$208K
- Maria HernandezMiami$197K
- George SanchezMiami$117K
- Jodie BarkinMiami$101K
- Javier ParraMiami$68K
- Samuel GidayOrlando$2M
- Jennifer Seminerio-DiehlOrlando$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.